Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy
- 19 March 2024
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 485, 116906
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Sichuan University West China Hospital of Stomatology
- Science and Technology Department of Sichuan Province
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
This publication has 42 references indexed in Scilit:
- RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progressionGenes & Diseases, 2024
- Combination of Peglated-H1/HGFK1 Nanoparticles and TAE in the Treatment of Hepatocellular CarcinomaApplied Biochemistry and Biotechnology, 2022
- Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancerPhytomedicine, 2021
- Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistantJournal of Controlled Release, 2021
- Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathwayCell Biology and Toxicology, 2020
- 3-O-Acetyl-11-keto- -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastomaActa Pharmaceutica Sinica B, 2020
- BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathwayJournal of Cellular Physiology, 2019
- 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins functionBiomedicine & Pharmacotherapy, 2019
- Differential resistance to platinum‐based drugs and 5‐fluorouracil in p22phox‐overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategiesHead & Neck, 2017
- The signaling mechanism of ROS in tumor progressionCancer and Metastasis Reviews, 2006